Status:
RECRUITING
Effects of Action Observation Therapy Based on Virtual Reality for Upper Extremity Rehabilitation in Stroke
Lead Sponsor:
Riphah International University
Conditions:
Stroke
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
This study aims to conduct a randomized controlled trial (RCT) assessing the effectiveness of combining Action Observation (AO) with Virtual Reality (VR) in improving upper limb function for stroke pa...
Detailed Description
The rehabilitation of paretic stroke patients uses a wide range of intervention programs to improve the function of impaired upper limb. A new rehabilitative approach, called action observation therap...
Eligibility Criteria
Inclusion
- • Both Male \& Female
- 40-60 years of age
- Primarily motor symptoms with unilateral upper limb paresis (controlled via standard neurological examination)
- Residual movement ability of the paretic upper limb, controlled by Medical Research Council (MRC) index (\> 2 and \< 4), active use of the hemiplegic limb, from minimal (mainly for assistance tasks to the preserved limb) to discrete (characterized by coarse manipulation and an inability to perform precision grip)
- mini-mental state examination (MME) score ≥27
- Sufficient cooperation and cognitive understanding to participate to the activities, controlled by the investigator recruiting the patient
Exclusion
- • Presence of severe cognitive impairment (score \< 20 at Mini Mental State Examination \[MMSE\])
- Presence of severe forms of unilateral spatial neglect, controlled using the Bells Test (cut-off = / \> 50%)
- Presence of severe ideomotor Apraxia
- Presence of severe anosognosia, assessed by clinical examination
- Presence of severe language comprehension deficits, assessed by clinical examination.
- Presence of severe untreated psychiatric disorders
- Sensory impairments hindering participation and/or not compensated visual deficits of central origin
- Drug-resistant epilepsy
Key Trial Info
Start Date :
November 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06196229
Start Date
November 25 2023
End Date
July 1 2024
Last Update
June 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riphah International University
Lahore, Punjab Province, Pakistan, 54000